9
СПИСОК ЛИТЕРАТУРЫ
1.Авдеев С.Н. Легочная гипертензия при хронической обструктивной болезни легких. Consilium Medicum, приложение «Системные гипертензии» 2004; выпуск 1: 5-11.
2.Авдеев С.Н., Царева Н.А., Неклюдова Г.В., Чучалин А.Г. Эффективность и безопасность ингаляционного оксида азота при острой легочной гипертензии у больных с обострением ХОБЛ. Пульмонология 2004; 2: 89-96.
3.Alp S, Skrygan M, Schmidt WE, et al. Sildenafil improves hemodynamic parameters in COPD-an investigation of six patients. Pulm Pharmacol Ther 2006; 1: 386-390.
4.Arias MA, Garcia-Rio F, Alonso-Fernandez A, et al. Pulmonary hypertension in obstructive sleep apnoea: effects of continuous positive airway pressure: a randomized, controlled cross-over study. Eur Heart J 2006; 27: 1106-1113.
5.Burgess MI, Mogulkoc N, Bright-Thomas RJ, Bishop P, Egan JJ, Ray SG. Comparison of echocardiographic markers of right ventricular function in determining prognosis in chronic pulmonary disease. J Am Soc Echocardiogr 2002; 15: 633-639.
6.Cazzola M, Mantero A, Santus P, et al. Doppler echocardiographic assessment of the effects of inhaled long-acting b2-agonists on pulmonary artery pressure in COPD patients. Pulm Pharmacol Ther 2007; 20: 258-264.
7.Chaouat A, Bugnet AS, Kadaoui N, et al. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 172: 189-194
8.Chaouat A, Weitzenblum E, Krieger J, et al. Pulmonary hemodynamics in the obstructive sleep apnea syndrome. Results in 220 consecutive patients. Chest 1996; 109: 380-386.
9.Fartoukh M, Humbert M, Capron F, et al. Severe pulmonary hypertension in histiocytosis X. Am J Respir Crit Care Med 2000; 161: 216-223.
10.Fletcher EC, Luckett RA, Goodnight-White SA, et al. A double-blind trial of nocturnal supplemental oxygen for sleep desaturation in patients with chronic obstructive pulmonary disease and a daytime PaO2 above 60 mm Hg. Am Rev Respir Dis 1992; 145: 1070-6.
11.Fujimoto K, Matsuzawa Y, Yamaguchi S, et al. Benefits of oxygen on exercise performance and pulmonary hemodynamics in patients with COPD with mild hypoxemia. Chest 2002; 122: 457-463.
12.Germann P, Ziescher R, Leitner C, et al. Addition of nitric oxide to oxygen improves cardiopulmonary function in patients with severe COPD. Chest 1998; 114: 29- 35.
13.Girgis RE, Mathai SC. Pulmonary hypertension associated with chronic respiratory disease. Clin Chest Med 2007; 28: 219-232.
14.Incalzi RA, Fuso L, De Rosa M, et al. Electrocardiographic signs of chronic cor pulmonale: A negative prognostic finding in chronic obstructive pulmonary disease. Circulation 1999; 99: 1600-1605.
15.Kanazawa H, Hirata K, Yoshikawa J Effects of captopril administration on pulmonary haemodynamics and tissue oxygenation during exercise in ACE gene subtypes in patients with COPD: a preliminary study. Thorax 2003; 58: 629-631.
16.Kessler R, Chaouat A, Schinkewitch P, Faller M, Casel S, Krieger J, et al. The obesity-hypoventilation syndrome revisited. A prospective study of 34 consecutive cases. Chest 2001; 120: 369 - 76.
17.Kessler R, Faller M, Fourgaut G, Mennecier B, Wietzenblum E. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159: 158- 164.
18.Kirshir B, Himelman RB, Schiller MB. Non-invasive estimation of right atrial pressure estimation from inspiratory collapse of the inferior vena cava. Am J Cardiol 1990; 16: 493-496.
19.Kitabatake A, Inoue M, Asao M, et al. Noninvasive evaluation of pulmonary hypertension by a pulsed doppler technique. Circulation 1983; 68: 302- 309
20.Kruger S, Haage P, Hoffmann R, et al. Diagnosis of pulmonary arterial hypertension and pulmonary embolism with magnetic resonance angiography. Chest 2001; 120: 1556-1561.
21.Lettieri CJ, Nathan SD, Barnett S, Ahmad S, Shorr AF. Prevalence and outcomes of pulmonary arterial hypertension in idiopathic pulmonary fibrosis. Chest 2006; 129: 746 - 752.
22.Leuchte HH, Baumgartner RA, Nounou ME, et al. Brain natriuretic peptide is a prognostic parameter in chronic lung disease. Am J Respir Crit Care Med 2006; 173: 744-750.
23.MacNee W. Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease, Part One. Am J Respir Crit Care Med 1994;150: 833-852 and 1158-1168.
24.Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981; i: 681- 686.
25.Morrell NW, Higham MA, Phillips PG, et al. Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease. Respiratory Research 2005; 6: 88 doi:10.1186/1465-9921-6-88.
26.Nadrous HF, Pellikka PA, Krowka MJ, Swanson KL, Chaowalit N, Decker PA, Ryu JH. Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Chest 2005; 128: 2393 - 2399.
27.Nathan S, Shlobin O, Ahmad S, et al. Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis. Chest 2007; 131: 657 - 663.
28.Neff AL, Petty TA. Long-term continuous oxygen therapy in chronic airway obstruction: mortality in relation to cor pulmonale, hypoxia and hypercapnia. Ann Intern Med 1970; 72: 621- 626.
29.Nekludova G, Naumenko J, Avdeeva O, Cherniaev A, Kalmanova E, Chuchalin A. Idiopathic pulmonary fibrosis: lung function parameters, pulmonary hypertension and hystologic changes. Eur Respir J 2000; 16: 87s.
30.Nunes H, Humbert M, Capron F, et al. Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis. Thorax 2006; 61: 68-74.
31.Olschewski H, Ghofrani HA, Walmrath D, et al. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis. Am J Respir Crit Care Med 1999; 160: 600-607.
32.Pepke-Zaba J, Morrell NW. Pulmonary hypertension in patients with COPD: NO treatment? Thorax 2003; 58: 289-293.
33.Rich S, Dantzker DR, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, et al. Primary pulmonary hypertension: a national prospective study. Ann Intern Med 1987; 107: 216-23.
34.Sajkov D, Wang T, Saunders NA, et al. Continuous positive airway pressure treatment improves pulmonary hemodynamics in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2002; 165: 152-158.
35.Scharf SM, Iqbal M, Keller C, Criner G, Lee S, Fessler HE. Hemodynamic characterization of patients with severe emphysema. Am J Respir Crit Care Med 2002; 166: 314- 322.
36.Schonhofer B, Barchfeld T, Wenzel M, Kohler D. Long term effects of non-invasive mechanical ventilation on pulmonary haemodynamics in patients with chronic respiratory failure. Thorax 2001; 56: 524- 528.
37.Thabut G, Dauriat G, Stern JB, et al. Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest 2005; 127: 1531-1536
38.Thorens JB, Ritz M, Reynard C, Righett A, Vallotton M, Favre H, Kyle U, Jolliet P, Chevrolet JC. Hemodynamic and endocrinological effects of noninvasive mechanical ventilation in respiratory failure. Eur Respir J 1997; 10: 2553- 2559.
39.Von Euler U, Lijestrand G. Observations on the pulmonary arterial blood pressure in cat. Acta Physiol Scand 1946; 12: 301- 320.
40.Vonbank K, Ziesche R, Higenbottam TW, Stiebellehner L, Petkov V, Schenk P, Germann P, Block LH. Controlled prospective randomised trial on the effects on pulmonary haemodynamics of the ambulatory long term use of nitric oxide and oxygen in patients with severe COPD. Thorax 2003; 58: 289-293.
41.Weitzenblum E, Hirth C, Ducolone A, Mirhom R, Rasaholinjanahary J, Ehrhart M. Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease. Thorax 1981; 36: 752- 758.
